Erlotinib and pyrexia Patient Reports February 11, 2012
Erlotinib Side Effects Report #5049846-X
Erlotinib side effect was reported by a Physician from UNITED STATES on June 23, 2006. Male patient, 48 years of age, was diagnosed with tonsil cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood chloride decreased, blood sodium decreased, malaise, neutrophil count increased, pyrexia, urine flow decreased, urine ketone body present. Erlotinib dosage: 100 MG, QD; ORAL. During the same period patient was treated with AVASTIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5345309-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 17, 2007. Female patient, 55 years of age, weighting 158.1 lb, was diagnosed with squamous cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dysphagia, oral discomfort, pyrexia. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, CARBOPLATIN, PACLITAXEL, FLUOROURACIL, RADIATION. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5371423-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 07, 2007. Female patient, 55 years of age, weighting 158.1 lb, was diagnosed with squamous cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dysphagia, feeding disorder, hypertension, oral discomfort, pyrexia. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, CARBOPLATIN, PACLITAXEL, FLUOROURACIL, RADIATION. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #4948887-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 09, 2006. Male patient, 47 years of age, weighting 183.9 lb, was diagnosed with squamous cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: heart rate increased, odynophagia, post procedural complication, pyrexia, viral infection
, white blood cell count decreased. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with AVASTIN, CISPLATIN, PRILOSEC, ZOFRAN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5914991-0
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 06, 2008. Male patient, weighting 225.0 lb, was diagnosed with squamous cell carcinoma, pain
, constipation
and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: hypotension, leukocytoclastic vasculitis, pyrexia. Erlotinib dosage: 100 MG, QD. During the same period patient was treated with AVASTIN, CISPLATIN, CIPROFLOXACIN, OXYCODONE, MIRALAX, PROTONIX. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5607508-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 10, 2008. Male patient, 58 years of age, was diagnosed with rectal cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, intestinal perforation, pyrexia. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5578434-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 12, 2007. Male patient, 77 years of age, was diagnosed with prostate cancer
and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, hypoxia, pneumocystis jiroveci pneumonia, pulmonary fibrosis
, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5380022-7
Erlotinib side effect was reported by a Physician from PERU on June 18, 2007. Female patient, 54 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, aspartate aminotransferase increased, blood glucose increased, dehydration, diarrhoea, nausea
, prothrombin time prolonged, pyrexia. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, GLYBURIDE, METFORMIN, ALPRAZOLAM, ACETAMINOPHEN, OMEPRAZOLE, TRAMADOL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5819961-9
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on July 09, 2008. Female patient, 75 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: candidiasis, dyspnoea, lung infection, malignant neoplasm progression, metastases to lung, oxygen saturation decreased, pyrexia. Erlotinib dosage: 150 MG, QD, DAYS 1-28, ORAL. During the same period patient was treated with SORAFENIB, GEMCITABINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5135875-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 06, 2006. Female patient, 69 years of age, weighting 108.0 lb, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: fistula
, incision site complication, pyrexia. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with CAPECITABINE, PANCREASE, PROTONIX, ZOLOFT, KLONOPIN, BENADRYL, DILAUDID, CIPRO. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5268193-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 14, 2007. Male patient, weighting 205.0 lb, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, diarrhoea, heart rate increased, pyrexia, respiratory rate increased. Erlotinib dosage: 150 MG ONCE A DAY PO. During the same period patient was treated with XELODA, PANCREASE, PREVACID, ZOLOFT, IMODIUM, ZOFRAN, LOMOTIL, TINCTURE OF OPIUM. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5731478-9
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 22, 2008. Male patient was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, hyperglycaemia, hyponatraemia, pyrexia, white blood cell count increased. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with EVEROLIMUS. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5776006-7
Erlotinib side effect was reported by a Physician from UNITED STATES on May 29, 2008. Male patient was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, ascites, chills, hyperglycaemia, hyponatraemia, malignant neoplasm progression, pyrexia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with EVEROLIMUS. Patient was hospitalized. Patient died on 05/18/2008.
Erlotinib Side Effects Report #5483736-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 09, 2007. Female patient, 78 years of age, weighting 184.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: decreased appetite, dehydration, malaise, nausea
, pyrexia. Erlotinib dosage: 150 MG DAILY 047. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5638845-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 22, 2008. Female patient, 78 years of age, weighting 184.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, pyrexia. Erlotinib dosage: 150 MG DAILY 047. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6068733-1
Erlotinib side effect was reported by a Health Professional from FRANCE on Jan 20, 2009. Male patient, 77 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: back pain
, pyrexia. Erlotinib dosage: (150 MG, QD), ORAL; (150 MG, QD), ORAL. During the same period patient was treated with DOXYCYCLINE, HYPERIUM, NICARDIPINE, NEXIUM, PREDNISOLONE, LASIX. Patient was hospitalized. Patient died on 04/30/2008.Erlotinib Side Effects Report #5062558-1
Erlotinib side effect was reported by a Physician from ITALY on July 05, 2006. Male patient, 76 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, pyrexia. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with LASIX, LOSARTAN POSTASSIUM, DIGOXIN, FLECAINIDE ACETATE, BISOPROLOL FUMARATE, RANITIDINE, METHYLPREDNISOLONE, SIMVASTATIN. Patient was hospitalized. Patient died on 06/30/2006.
Erlotinib Side Effects Report #4996245-2
Erlotinib side effect was reported by a Physician from HONG KONG on Apr 21, 2006. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, cardio-respiratory arrest, duodenal ulcer perforation, pneumoperitoneum, pyrexia. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died on 02/23/2006.Erlotinib Side Effects Report #5642767-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 27, 2008. Female patient, 71 years of age, weighting 145.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchitis
, chronic obstructive pulmonary disease, cough, lethargy, pyrexia, viral infection
. Erlotinib dosage: 150MG , ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6023554-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Dec 26, 2008. Male patient, 71 years of age, weighting 156.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, dehydration, diarrhoea, liver function test abnormal, pyrexia, renal failure acute, rhabdomyolysis. Erlotinib dosage: 150 MG DAILY 047 PO. During the same period patient was treated with BEVACIZUMAB, ZOFRAN, FENTANYL, MARINOL, RELISTOR, CORTISONE ACETATE, SYTHROID, TRAZODONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6028903-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 05, 2009. Male patient, 71 years of age, weighting 156.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, dehydration, diarrhoea, faecal incontinence, lethargy, liver function test abnormal, pyrexia, renal failure acute, rhabdomyolysis. Erlotinib dosage: 150 MG DAILY 047 PO. During the same period patient was treated with BEVACIZUMAB, ZOFRAN, FENTANYL, MARINOL, RELISTOR, CORTISONE ACETATE, SYTHROID, TRAZODONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5897708-8
Erlotinib side effect was reported by a Health Professional from GERMANY on Sept 08, 2008. Male patient, 68 years of age, weighting 194.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pancytopenia, pyrexia. Erlotinib dosage: (150 MG, 1 IN 1 D), ORAL. During the same period patient was treated with PEMETREXED, RITUXIMAB, PANTOPRAZOLE, GLIMEPIRIDE, METFORMIN, METOPROLOL TARTRATE, HYDROCHLOROTHIAZIDE, ENOXAPARIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5081340-2
Erlotinib side effect was reported by a Physician from UNITED STATES on June 23, 2006. Female patient, 65 years of age, weighting 175.7 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: back pain
, bacterial infection
, culture urine positive, pyrexia, renal colic, urinary tract infection
. Erlotinib dosage: 15 MG/KG, Q2W, ORAL. During the same period patient was treated with AVASTIN, CIPROFLOXACIN, HYDROCHLOROTHIAZIDE, MYLANTA, PRILOSEC, IBUPROFEN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5678358-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 07, 2008. Female patient, 62 years of age, weighting 158.7 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cerebral ischaemia, encephalopathy, haemoglobin decreased, lethargy, metastases to liver, muscular weakness, pyrexia. Erlotinib dosage: 150 MG (QD),ORAL; D. During the same period patient was treated with ASPIRIN, DEXAMETHASONE, INSULIN, LEVAMIR, LIPITOR, PAXIL, TRENTAL, PREMETREXED. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5869425-1
Erlotinib side effect was reported by a Health Professional from SWITZERLAND on Aug 13, 2008. Female patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cough, pleural effusion, pneumonia
, pyrexia, rhinitis. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5925140-7
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 20, 2008. Male patient, 62 years of age, weighting 189.6 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6003588-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 12, 2008. Male patient, 62 years of age, weighting 189.6 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #4901777-9
Erlotinib side effect was reported by a Pharmacist from UNITED STATES on Feb 01, 2006. Female patient, 62 years of age, weighting 74.50 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, dyspnoea, hyperhidrosis, pruritus, pyrexia, rash
. Erlotinib dosage: 150MG DAILY PO. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5798945-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 16, 2008. Male patient, 59 years of age, weighting 166.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest pain
, cough, fatigue, hyperhidrosis, nephritis interstitial, pyrexia, renal failure, rhinorrhoea. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with METOPROLOL TARTRATE, LOPERAMIDE HYDROCHLORIDE, PAREGORIC, ACETAMINOPHEN, VITAMIN B6, IRON. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5840320-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 28, 2008. Male patient, 59 years of age, weighting 166.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, chest pain
, cough, disease progression, hyperhidrosis, pyrexia, renal cyst, renal failure, rhinorrhoea. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with METOPROLOL TARTRATE, LOPERAMIDE HYDROCHLORIDE, PAREGORIC, VITAMIN B6, IRON. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5800770-1
Erlotinib side effect was reported by a Physician from ITALY on June 17, 2008. Female patient, 58 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiopulmonary failure, cough, pyrexia. Erlotinib dosage: (150 MG,QD), ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5979440-5
Erlotinib side effect was reported by a Physician from ARGENTINA on Nov 13, 2008. Male patient, 55 years of age, weighting 211.6 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cyanosis, increased bronchial secretion, infection
, lung infiltration, pyrexia, respiratory failure. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with ACETYLCYSTEINE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5739357-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 29, 2008. Male patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood albumin decreased, blood alkaline phosphatase increased, dehydration, diarrhoea, metastases to lung, pneumonia
, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with HYDROCODONE, ACETAMINOPHEN, DIPHENHYDRAMINE, CEPHALEXIN, IBUPROFEN, LOPERAMIDE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5670021-X
Erlotinib side effect was reported by a Health Professional from HUNGARY on Feb 27, 2008. Male patient, 49 years of age, weighting 249.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, dermatitis acneiform, fatigue, febrile neutropenia, headache
, pyrexia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with PEMETREXED, TIOTROPIUM BROMIDE, FOLIC ACID, VITAMIN B12, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5852682-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 19, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5873762-4
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 04, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5875062-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 08, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile toxin test positive, dehydration, diarrhoea, haemoglobin decreased, nausea
, pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5885500-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 15, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile toxin test positive, dehydration, diarrhoea, haemoglobin decreased, nausea
, pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5885506-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 15, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5910478-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 06, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, clostridium difficile colitis, dehydration, diarrhoea, nausea
, pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5920061-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 30, 2008. Male patient, 47 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood potassium decreased, blood sodium decreased, clostridium difficile colitis, dehydration, haemoglobin decreased, ileus, nausea
, pyrexia, small intestinal obstruction. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5944242-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 20, 2008. Male patient, 47 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile colitis, dehydration, diarrhoea, haemoglobin decreased, nausea
, pseudomembranous colitis, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #4816217-8
Erlotinib side effect was reported by a Consumer or non-health professional from SINGAPORE on Oct 04, 2005. Male patient, 46 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cough, lethargy, pleural effusion, pleuritic pain, pyrexia. Erlotinib dosage: 150 MG 1 X PER DAY / ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5922912-X
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Oct 03, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pyrexia. Erlotinib dosage: 150 MG, UNK. During the same period patient was treated with BEVACIZUMAB, TEMAZEPAM, MINOCYCLINE, RABEPRAZOLE, CODEINE SUL, PAROXETINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5965063-0
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Nov 10, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pyrexia. Erlotinib dosage: 150 MG, UNK. During the same period patient was treated with BEVACIZUMAB, TEMAZEPAM, MINOCYCLINE, RABEPRAZOLE, CODEINE SUL, PAROXETINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5088038-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Aug 14, 2006. Male patient, 53 years of age, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, condition aggravated, haemoglobin decreased, hiccups, neutrophil count decreased, odynophagia, pharyngolaryngeal pain, pyrexia. Erlotinib dosage: 100 MG QD ORAL. During the same period patient was treated with AVASTIN, CISPLATIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6083054-9
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 13, 2009. Male patient, weighting 127.5 lb, was diagnosed with nasopharyngeal cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, hypophagia, lymphopenia, pyrexia, white blood cell count decreased. Erlotinib dosage: 100 MG, QD. During the same period patient was treated with BEVACIZUMAB, CISPLATIN, ONDANSETRON, ACETAMINOFEN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6087966-1
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 19, 2009. Male patient, weighting 127.5 lb, was diagnosed with nasopharyngeal cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, hypophagia, lymphopenia, pyrexia, white blood cell count decreased. Erlotinib dosage: 100 MG, QD. During the same period patient was treated with BEVACIZUMAB, CISPLATIN, ONDANSETRON, ACETAMINOFEN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6092896-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 20, 2009. Male patient, weighting 127.5 lb, was diagnosed with nasopharyngeal cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: constipation
, dehydration, nausea
, pyrexia. Erlotinib dosage: 100 MG, QD. During the same period patient was treated with BEVACIZUMAB, CISPLATIN, ONDANSETRON, ACETAMINOFEN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6084302-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 17, 2009. Male patient, 40 years of age, weighting 27.50 lb, was diagnosed with nasal sinus cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, flatulence, hypophagia, pyrexia. Erlotinib dosage: 100MG/ORAL DAILY. During the same period patient was treated with BEVACIZUMAB, ACETAMINOPHEN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6140770-8
Erlotinib side effect was reported by a Physician from GREECE on Mar 17, 2009. Female patient, 61 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pulmonary embolism
, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DOCETAXEL, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5930610-1
Erlotinib side effect was reported by a Health Professional from CANADA on Oct 06, 2008. Female patient, 57 years of age, weighting 110.2 lb, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pyrexia, spinal cord compression. Erlotinib dosage: (150 MG), ORAL. Patient died on 09/13/2008.
Erlotinib Side Effects Report #5822588-6
Erlotinib side effect was reported by a Physician from JAPAN on July 11, 2008. Male patient, 79 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood pressure decreased, interstitial lung disease, pyrexia, rash
. Erlotinib dosage: (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5897654-X
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 08, 2008. Male patient, 79 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood pressure decreased, interstitial lung disease, pyrexia, rash
. Erlotinib dosage: (150 MG,QD), ORAL. Patient was hospitalized. Patient died on 07/05/2008.Erlotinib Side Effects Report #5731802-7
Erlotinib side effect was reported by a Health Professional from JAPAN on Apr 22, 2008. Female patient, 75 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, haemoptysis, interstitial lung disease, pulmonary alveolar haemorrhage, pyrexia. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with LANIRAPID, VERAPAMIL HYDROCHLORIDE, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5889278-5
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 02, 2008. Male patient, 73 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pyrexia, rash
, white blood cell count increased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with METHYCOBAL, PREDONINE, ALTAT, MOBIC, SENNOSIDES, ALESION, MOHRUS. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6128091-0
Erlotinib side effect was reported by a Physician from JAPAN on Mar 05, 2009. Female patient, 72 years of age, weighting 121.3 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, pyrexia, rash
. Erlotinib dosage: 150 MG, QD, ORAL; 100 MG, QD, ORAL. During the same period patient was treated with CANDESARTAN CILEXETIL, NEUROTROPIN, TIZANIDINE, MESITAT, MICODYNE, TAGAMET, APLACE. Patient recovered.Erlotinib Side Effects Report #5788681-1
Erlotinib side effect was reported by a Physician from JAPAN on June 09, 2008. Male patient, 69 years of age, was diagnosed with lung adenocarcinoma, pyrexia and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: c-reactive protein increased, disease progression, dyspnoea, pruritus, pyrexia, rash
, rhinorrhoea. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with FINIBAX, ADALAT, MUCODYNE, HOKUNALIN, THEOLONG, PREDONINE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5818453-0
Erlotinib side effect was reported by a Physician from JAPAN on July 03, 2008. Male patient, 69 years of age, was diagnosed with lung adenocarcinoma, pyrexia and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: c-reactive protein increased, disease progression, dyspnoea, pruritus, pyrexia, rash
, rhinorrhoea. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with FINIBAX, ADALAT, MUCODYNE, HOKUNALIN, THEOLONG, PREDONINE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5878594-9
Erlotinib side effect was reported by a Physician from JAPAN on Aug 25, 2008. Male patient, 68 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atrial fibrillation
, bacterial infection
, c-reactive protein increased, cardiac failure chronic, pyrexia, rash papular, rash pustular. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with CODEINE PHOSPHATE, MAGNESIUM OXIDE, CARVEDILOL, LASIX, DIGOXIN, DILTIAZEM HYDROCHLORIDE, AMARUL, WARFARIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5979444-2
Erlotinib side effect was reported by a Physician from JAPAN on Nov 13, 2008. Male patient, 68 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, infection
, left ventricular dysfunction, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with AMLODIPINE BESYLATE, MICARDIS, HARNAL, BASEN, GLUFAST, NOVOLIN N, GASMOTIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6025538-5
Erlotinib side effect was reported by a Physician from JAPAN on Dec 16, 2008. Male patient, 68 years of age, weighting 127.9 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: c-reactive protein increased, pyrexia, rash papular, rash pustular. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with CODEINE PHOSPHATE, MAGNESIUM OXIDE, CARVEDILOL, LASIX, DIGOXIN, DILTIAZEM HYDROCHLORIDE, AMARYL, WARFARIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5900778-1
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 12, 2008. Male patient, 67 years of age, weighting 132.3 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: c-reactive protein increased, dizziness
, eye disorder, infection
, paraesthesia oral, pyrexia, rash
. Erlotinib dosage: (150 MG, QD), ORAL; (100 MG, QD), ORAL. During the same period patient was treated with MAGLAX, LASIX, ACECOL, ASPIRIN, IRESSA. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5917589-3
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 24, 2008. Male patient, 65 years of age, weighting 121.5 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: condition aggravated, dehydration, delirium, disease progression, pneumonia bacterial, pyrexia, renal impairment. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with NOVAMIN, LOXONIN, FAMOTIDINE, MUCODYNE, OXYCONTIN, MAGMITT, PRIMPERAN, CLONAZEPAM. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5721522-7
Erlotinib side effect was reported by a Physician from JAPAN on Apr 14, 2008. Male patient, 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bone marrow failure, pulmonary embolism
, pyrexia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with IRINOTECAN, MUCOSTA, ETODOLAC, MAGNESIUM OXIDE. Patient recovered.Erlotinib Side Effects Report #5878592-5
Erlotinib side effect was reported by a Physician from JAPAN on Aug 26, 2008. Male patient, 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bone marrow failure, decreased appetite, pulmonary embolism
, pyrexia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with IRINOTECAN, MUCOSTA, ETODOLAC, MAGNESIUM OXIDE. Patient recovered.Erlotinib Side Effects Report #5963876-2
Erlotinib side effect was reported by a Physician from JAPAN on Nov 05, 2008. Male patient, 56 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: lymphocyte count decreased, pyrexia, rash
, rectal ulcer haemorrhage. Erlotinib dosage: 150 MG QD ORAL. During the same period patient was treated with GLYCEROL, LANSOPRAZOLE, ZOLPIDEM TARTRATE, PURSENNID, OXYCONTIN, NOVAMIN, ALUMINUM HYDROXIDE, MUCOSTA. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5647980-4
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 13, 2008. Female patient, 45 years of age, weighting 131.8 lb, was diagnosed with glioblastoma multiforme and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: aneurysm
, disease progression, hypoalbuminaemia, hypocalcaemia, pyrexia. Erlotinib dosage: (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5681116-9
Erlotinib side effect was reported by a Physician from DENMARK on Mar 10, 2008. Female patient, 66 years of age, was diagnosed with gastrointestinal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, dehydration, pulmonary oedema, pyrexia, somnolence. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, CONTALGIN, DURAGESIC, IMOZOP, MOTRIN, OMEPRAZOLE, MOVICOL, TRADOLAN. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5019505-8
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2006. Female patient, weighting 200.6 lb, was diagnosed with colon cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, diarrhoea, fatigue, mucosal exfoliation, neutropenia, pyrexia, white blood cell count abnormal. Erlotinib dosage: 100 MG DAILY ORAL. During the same period patient was treated with FLUOROURACIL, OXALIPLATIN, AVASTIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #4815154-2
Erlotinib side effect was reported by a Health Professional from SINGAPORE on Oct 10, 2005. Male patient, 46 years of age, was diagnosed with bronchial neoplasm, lung neoplasm and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest x-ray abnormal, condition aggravated, lung infiltration, mediastinal disorder, pleural effusion, pleuritic pain, pyrexia, rash
. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6075570-0
Erlotinib side effect was reported by a Physician from JAPAN on Jan 26, 2009. Male patient, 77 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dry skin, hypoglycaemia, liver disorder, paronychia, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with NICORANDIL, AMARYL, ADALAT, METFORMIN, BASEN, LASIX, ALDACTONE, ISOSORBIDE DINITRATE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5736917-5
Erlotinib side effect was reported by a Physician from JAPAN on May 02, 2008. Male patient, 69 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: catheter related infection, erythema multiforme, hepatic function abnormal, oral herpes, pyrexia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with LOXONIN, FAMOTIDINE, LENDORM, FUNGIZONE, DECADRON, ROCEPHIN, RISPERDAL, GRAMALIL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5015294-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 30, 2006. Male patient, 47 years of age, weighting 164.0 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: neutrophil count decreased, pyrexia, viral infection
, white blood cell count decreased. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, ZOFRAN, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5016559-X
Erlotinib side effect was reported by a Physician from UNITED STATES on May 31, 2006. Male patient, 47 years of age, weighting 164.0 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: hypovolaemia, pneumonia aspiration, pyrexia. Erlotinib dosage: 100MG DAILY. During the same period patient was treated with AVASTIN, CISPLATIN, ZOFRAN, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5394594-X
Erlotinib side effect was reported by a Physician from UNITED STATES on July 06, 2007. Female patient, 44 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, diarrhoea, gingival bleeding, hypokalaemia, hyponatraemia, nausea
, pancytopenia, pyrexia. Erlotinib dosage: 75 MG (QD), ORAL. During the same period patient was treated with PEGINTERFERON ALFA, SUTENT, CELEXA, VERAPAMIL, NORTRIPTYLINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5932680-3
Erlotinib side effect was reported by a Physician from JAPAN on Oct 09, 2008. Male patient, 26 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, nausea
, pyrexia, rash
. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with OXYCONTIN, NOVAMIN, MORPHINE, MAGMITT, PURSENNID, LOXONIN, MUCOSTA. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5273618-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 21, 2007. Male patient, weighting 205.0 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea haemorrhagic, hypokalaemia, pyrexia. Erlotinib dosage: unknown. During the same period patient was treated with XELODA. Patient was hospitalized. Patient recovered.
Erlotinib and pyrexia 